GOEMAN, C. J. The Price Isn’t Right: Shareholder Proposals as Opportunities for Institutional Investors to Restore Firm Value and Reduce Pharmaceutical Prices. Columbia Business Law Review, [S. l.], v. 2017, n. 2, p. 748–806, 2017. DOI: 10.7916/cblr.v2017i2.1723. Disponível em: https://journals.library.columbia.edu/index.php/CBLR/article/view/1723. Acesso em: 18 jul. 2024.